Vaxcyte, Inc. (PCVX)
54.24
-1.24
(-2.24%)
USD |
NASDAQ |
Mar 18, 15:59
54.07
-0.16
(-0.30%)
After-Hours: 17:12
Vaxcyte Shareholders Equity (Quarterly) : 2.686B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Corcept Therapeutics, Inc. | 647.80M |
| Cytokinetics, Inc. | -659.62M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
| Sutro Biopharma, Inc. | -87.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.046B |
| Total Liabilities (Quarterly) | 360.46M |
| Debt to Equity Ratio | 0.0437 |
| Current Ratio | 7.909 |
| Net Debt Paydown Yield | -0.30% |